When the CDC updated its variant prevalence estimates this week, the agency added new versions of Omicron to the dashboard. In the U.S., COVID-19 cases are now driven by: BA.5, BA.4.6, BQ.1, BQ.1.1, BF.7, BA.2.75, and BA.2.75.2. And possibly more subvariants that we aren’t tracking yet.
While official case numbers remain low compared to past fall seasons—both national cases and hospital admissions dropped again this week—signals of a coming fall surge are accumulating from wastewater and local data. According to Biobot’s dashboard, the coronavirus continues to spread in the Northeast at higher levels than the rest of the country with a new uptick this week.
This week, the CDC announced a big change to its COVID-19 data reporting: instead of updating case and death numbers daily, the figures will be updated weekly. The change comes into effect on October 20.
As you might have guessed from the last couple weeks of National numbers posts, I am anticipating that the U.S. will see a new COVID-19 surge this fall, along with potential surges of the flu and other respiratory diseases. Here’s why it’s worth worrying about possible surges, and some thoughts on better tracking these viruses in the future.
Following a pattern from the last couple of months, national COVID-19 cases and hospitalizations continued to trend slightly downward this week—though local indicators suggest we may experience a fall surge soon.
On September 2, 2022, the federal government stopped taking orders for free at-home COVID-19 tests. The day this program ended, I sent a public records request to the federal government asking for data on how many tests were distributed. I just received some data back from my request; here’s what the numbers show.